Marek Łos
Los, Marek
VIAF ID: 315215492 (Personal)
Permalink: http://viaf.org/viaf/315215492
Preferred Forms
-
- 100 0 _ ‡a Marek Łos
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Cancer stem cell markers in common cancers - therapeutic implications | |
Cancer stem cells as targets for cancer therapy: selected cancers as examples. | |
Cancer stem cells, cancer-initiating cells and methods for their detection | |
Caspases and cancer: mechanisms of inactivation and new treatment modalities | |
Caspases: more than just killers? | |
Caspases--their role in apoptosis and other physiological processes as revealed by knock-out studies. | |
Catching chromatin relaxation in act by flow cytometry. | |
Cell type related differences in staining with pentameric thiophene derivatives. | |
Chemosensitivity of solid tumor cellsin vitro is related to activation of the CD95 system | |
Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer | |
Composite Nanofibers Containing Multiwall Carbon Nanotubes as Biodegradable Membranes in Reconstructive Medicine | |
The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells. | |
Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells | |
Different faces of hepatocellular carcinoma as a health threat in 21st century | |
Differential vital staining of normal fibroblasts and melanoma cells by an anionic conjugated polyelectrolyte. | |
Direct Mechanical Stimulation of Stem Cells: A Beating Electromechanically Active Scaffold for Cardiac Tissue Engineering. | |
An efficient approach for the isolation, identification and evaluation of antimicrobial plant components on an analytical scale, demonstrated by the example of Radix imperatoriae. | |
Ehrlichia chaffeensis uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cells | |
The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation. | |
An Fc gamma receptor I (CD64)-negative subpopulation of human peripheral blood monocytes is resistant to killing by antigen-activated CD4-positive cytotoxic T cells | |
Functional characterization of DNase X, a novel endonuclease expressed in muscle cells | |
Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases. | |
Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death | |
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | |
Heterogeneous Mixture of Amniotic Cells is Likely a Better Source of Stem Cells than Adipose Tissue | |
HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells | |
HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM) | |
Human Gyrovirus-Apoptin Interferes with the Cell Cycle and Induces G2/M Arrest Prior to Apoptosis. | |
Human-gyrovirus-Apoptin triggers mitochondrial death pathway--Nur77 is required for apoptosis triggering | |
Human induced pluripotent stem cell differentiation and direct transdifferentiation into corneal epithelial-like cells | |
Hydrogen peroxide as a potent activator of T lymphocyte functions | |
Identification of poly(ADP-ribose)polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression | |
Impact of Antibiotics on the Proliferation and Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. | |
Important differences between topoisomerase-I and -II targeting agents | |
Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins. | |
Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin | |
Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development | |
LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta-analysis | |
LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies | |
Mapping of apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy | |
Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. | |
Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine | |
Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53 | |
Mitoptosis, a novel mitochondrial death mechanism leading predominantly to activation of autophagy | |
Modeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug design | |
Monitoring of autophagy is complicated--salinomycin as an example. | |
Monoclonal and bispecific antibodies as novel therapeutics | |
Neuropathological and genomic characterization of glioblastoma-induced rat model: How similar is it to humans for targeted therapy? | |
New, exciting developments in experimental therapies in the early 21st century. | |
New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets | |
New potential instrument to fight hepatocellular cancer by restoring p53 | |
Novel trends in application of stem cells in skin wound healing | |
Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1). | |
Obesity: pathophysiology and clinical management | |
An overview of Brevinin superfamily: structure, function and clinical perspectives | |
Peptide-based approaches to treat asthma, arthritis, other autoimmune diseases and pathologies of the central nervous system. | |
Photodynamic N-TiO2 Nanoparticle Treatment Induces Controlled ROS-mediated Autophagy and Terminal Differentiation of Leukemia Cells | |
Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress | |
Prolonged survival and expression of neural markers by bone marrow-derived stem cells transplanted into brain lesions | |
Prospects and limitations of "Click-Chemistry"-based DNA labeling technique employing 5-ethynyl-2'deoxyuridine (EdU). | |
Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus | |
Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. | |
Rational Design of a Conductive Collagen Heart Patch. | |
Redox events in HTLV-1 Tax-induced apoptotic T-cell death | |
Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. | |
Reprogramming and carcinogenesis--parallels and distinctions | |
Rhodamine 110-Linked Amino Acids and Peptides as Substrates To Measure Caspase Activity upon Apoptosis Induction in Intact Cells† | |
Role of BNIP3 in TNF-induced cell death--TNF upregulates BNIP3 expression | |
The role of caspases in cryoinjury: caspase inhibition strongly improves the recovery of cryopreserved hematopoietic and other cells | |
The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. | |
The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. | |
Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression | |
Role of the salt bridge between glutamate 546 and arginine 907 in preservation of autoinhibited form of Apaf-1. | |
S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. | |
S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway | |
S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3 | |
Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells | |
en scientific article | |
Selected technologies to control genes and their products for experimental and clinical purposes. | |
Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. | |
Spatiotemporal cytometry-simultaneous analysis of DNA replication and damage. | |
Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. | |
Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development | |
Structure and properties of slow-resorbing nanofibers obtained by (co-axial) electrospinning as tissue scaffolds in regenerative medicine. | |
Switching Akt: from survival signaling to deadly response | |
Tabibi Sabbu | |
Targeting the EGFR pathway for cancer therapy | |
Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences | |
The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. | |
Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity. | |
Viral modulation of cell death by inhibition of caspases. | |
Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development |